Hao Luo

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Epidermal Growth Factor Receptor

Top Venues

Journal of immunology research

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Dan Jian, Xue-Mei Li, Nan Dai, Dan-Dan Liang, Gang Zhang, Cheng-Yi Mao, Dong Wang, Guan-Bin Song, Meng-Xia Li, Hao Luo
Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Hao Luo, Gao-Lei Liu, Dan Jian, Dan-Dan Liang, Xue-Mei Li, Li Zhong, Bo Yang, Jun Jiang, Dong Wang, Meng-Xia Li, Wei-Hua Lan, Nan Dai
Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. Journal of immunology research 2022 (2022)